#WeAreLilly - 37,000 global employees #PoweredbyPurpose "Alzheimer's disease is relentless. It can be a thief of one's humanity, and although that seems very dark, it serves as motivation to rewrite the narrative to something brighter. Relentless is also how I describe Lilly's commitment to Alzheimer’s. I have been inspired to see the analog of Colonel Lilly's "take what you find here and make it better and better" come to bear in our clinical trial programs. With each negative study, we have learned something and improved the following study so we can get closer and closer to the answer on behalf of patients. As a behavioral neurologist and clinician educator in academic practice, I spent my days caring for patients with neurodegenerative diseases and their families, conducting clinical research, and teaching others about dementia. In clinical practice, developing a personal relationship with a patient and their family, I often observed the devastation and dynamics of living with A...